Sir,

A 38-year-old lady who presented at our institute in February 2012 with generalized lymphadenopathy was diagnosed as follicular lymphoma (FL) (grade-III, stage-IV) \[[Figure 1a](#F1){ref-type="fig"}\]. Immuno--histochemically (IHC), the tumor cells showed positivity to BCL 2 \[[Figure 1b](#F1){ref-type="fig"}\], MIB 60-70% \[[Figure 1c](#F1){ref-type="fig"}\], CD20 \[[Figure 1d](#F1){ref-type="fig"}\], CD79α, CD10 and BCL6. Bone marrow biopsy showed marrow involvement. Follow-up computed tomography after 4 cycles of CHOP (Cyclophosphamide, Hydroxydaunorubicin, Oncovin, Prednisolone) showed residual lymphadenopathy and hepato-splenomegaly. Total white blood cell count (TWBC) was 4.8 × 10^6^/L, with 62% lymphoid cells, no blasts. Subsequent lymph node biopsy showed features of high grade diffuse large B cell lymphpma (DLBCL, Burkitt\'s like) \[[Figure 2a](#F2){ref-type="fig"}\]. IHC showed positivity to CD20, CD79α, BCl2 \[[Figure 2b](#F2){ref-type="fig"}\], MIB 80% \[[Figure 2c](#F2){ref-type="fig"}\], CD10 \[[Figure 2d](#F2){ref-type="fig"}\] and BCL6, and negative to terminal deoxynucleotidyl transferase, CD99 and Cyclin-D1. Bone marrow showed residual disease with few blasts. Assessment after 2 more cycles (August 2012) showed persistent lymphadenopathy, TWBC: 7 × 10^6^/L with 10% L3 type blasts \[[Figure 3d](#F3){ref-type="fig"}\], bone marrow aspiration: 80% L3 type blasts \[[Figure 3b](#F3){ref-type="fig"}\], bone marrow biopsy showed sheets of blasts \[Figure [3a](#F3){ref-type="fig"} and [c](#F3){ref-type="fig"}\]. Flow-cytometry: Positive for CD5, CD20, CD21, CD33, FMC7, Kappa. CD23 was negative. The patient showed transformation of FL to high-grade DLBCL and acute lymphoblastic leukemia of L3 type.

![(a) H and E, ×10 - Follicular lymphoma showing neoplastic follicles; (b) Bcl-2, ×10 - Neoplastic follicles showing strong positivity; (c) Ki-67, ×10 - Neoplastic follicles showing strong proliferative activity; (d) CD-20 ×20 - Neoplastic cells showing positive reaction](IJMPO-34-136-g001){#F1}

![(a) H and E, ×100 - Diffuse high grade Burkitt\'s like lymphoma; (b) BCL2, ×100 - Atypical cells showing positive reaction; (c) Ki-67, ×40 - Atypical cells showing high proliferative activity; (d) CD10, ×40 - Atypical cells showing strong membrane positivity](IJMPO-34-136-g002){#F2}

![(a) H and E, ×100 - Bone marrow biopsy showing sheets of blasts; (b) Leishman\'s stain, ×100 - Bone marrow aspiration showing many blasts with L3 morphology; (c) Leishman\'s stain, ×100 - Bone marrow biopsy touch imprint smear showing blasts with L3 morphology; (d) Leishman\'s stain, ×100 - Peripheral smear showing blast with L3 morphology](IJMPO-34-136-g003){#F3}

FL is an indolent lymphoma. Blastic transformation though rare has highly aggressive course. Our patient was advised supportive care as she had poor response to treatment and was not fit for intensive chemotherapy.
